Chas McKhann - Mar 1, 2024 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Role
Chief Executive Officer, Director
Signature
/s/Mhairi Jones, by power of attorney
Stock symbol
SILK
Transactions as of
Mar 1, 2024
Transactions value $
$0
Form type
4
Date filed
3/5/2024, 06:17 PM
Previous filing
Nov 3, 2023
Next filing
Sep 18, 2024
SEC
View on sec.gov

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. 25% of the shares shall vest on March 1, 2025 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.